| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.67M | - | |
| Other | 52.8K | $8.52M | - | |
| Other | 46.8K | $7.55M | - | |
| Other | 39.6K | $6.40M | -36,937 | |
| Other | 36.8K | $5.95M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | Roberts Eiry49 | Chief Medical Officer | Sell | 2,363 | $116.78 | $275,943.91 | -6.2% | |
| Feb 8, 2021 | Abernethy Matt57 | Chief Financial Officer | Sell | 2,910 | $116.82 | $339,941.51 | -9.4% | |
| Feb 8, 2021 | Benevich Eric62 | Chief Commercial Officer | Sell | 5,079 | $116.38 | $591,088.69 | -6.4% | |
| Feb 8, 2021 | Cooke Julie59 | Chief Human Resources Officer | Sell | 1,943 | $115.84 | $225,075.71 | -4.8% | |
| Feb 8, 2021 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 4,126 | $116.26 | $479,668.44 | -3.2% | |
| Feb 8, 2021 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 3,313 | $116.16 | $384,821.80 | -1.0% | |
| Feb 8, 2021 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 12,888 | $116.26 | $1,498,368.03 | -0.7% | |
| Feb 8, 2021 | Gano Kyle54 | Chief Business Development Off | Sell | 6,370 | $115.65 | $736,702.16 | -1.2% | |
| Feb 8, 2021 | Bozigian Haig P. | Chief Development Officer | Sell | 4,546 | $116.33 | $528,857.09 | -0.7% | |
| Jan 26, 2021 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sale+OE | 18,670 | $119.97 | $2,239,777.48 | -11.4% |